Prognostic utility of preoperative platelet-to-albumin ratio in surgically treated oral cavity cancer patients: Assessing the prognostic impact: Platelet-to-albumin ratio in surgically treated oral cavity cancer patients.
Yao-Te TsaiKu-Hao FangMing-Hsien TsaiChia-Hsuan LaiChien-An KoMing-Shao TsaiGeng-He ChangChun-Ta LiaoChung-Jan KangCheng-Ming HsuEthan I HuangYi-Chan LeeYuan-Hsiung TsaiChih-Wei LuanPublished in: Head & neck (2023)
The preoperative PAR is a promising and cost-effective prognostic biomarker for patients with surgically-treated OSCC; the PAR-based nanogram accurately predicts OS for such patients.